MVision AI

Koti
Suomi
Helsinki
MVision AI

Yhteystiedot, kartta ja reittiohjeet, yhteydenottolomake, aukioloajat, palvelut, arvostelut, kuvat, videot ja ilmoitukset MVision AI, Terveys, PaciuksenKatu 29, Helsinki :ltä.

MVision develops AI-powered solutions that automate repetitive tasks, enable efficient radiotherapy workflows, and promote consistency across clinical processes.

24/04/2026

Back for day two at Sädehoitopäivät (Finnish Radiotherapy Days).

Great conversations yesterday and a lot of interest around MVision Workspace+® and how it can support more efficient radiotherapy treatment preparation workflows.

We look forward to more discussions before the event wraps up.

22/04/2026

Are you going to and looking to learn more about MVision's AI-powered solutions? Book a demo and experience our latest innovations firsthand.

📍 Booth C14:31
🗓️ May 15–18 | Stockholm
🔗 Reserve your time: https://bit.ly/4vK4MEQ

At the booth, you can explore MVision Workspace+® — our AI platform for radiotherapy — and see live demonstrations of the full platform and/or its individual modules:

➤ Contour+
➤ Dose+
➤ Image+
➤ Adapt+

Be sure to ask about our latest exciting updates and what’s coming next.

Is there anything else you'd like to explore during your session? You can also use the booking form to tell us what you would like to discuss. Our team will tailor the session to your interests and clinical priorities.

We look forward to welcoming you to the booth and exploring how our AI-powered solutions can support efficient radiotherapy preparation.

*CE-marked (CE 2797) medical device under EU MDR 2017/745; Workspace+ is not available in all markets.

21/04/2026

Another important radiotherapy meeting, but this time much closer to home.

MVision AI will be attending Sädehoitopäivät (Finnish Radiotherapy Days) in Kuopio, Finland on April 23–24. The program focuses on the preparation of radiotherapy treatments and the practical use of new technologies in everyday clinical work. It offers an opportunity to exchange experience and learn from colleagues across the field.

You can meet our Founder and CEO Mahmudul Hasan and Product Owner Jani Pehkonen during the exhibition.

Stop by our table to connect!

20/04/2026

Thank you to everyone who visited us at the International Technical Exhibition of Medical Imaging (ITEM2026) in Yokohama.

It was a pleasure to reconnect with partners and meet new professionals exploring how AI can be integrated into everyday clinical workflows. The conversations throughout the exhibition reflected a strong interest in practical, reliable tools that support medical imaging and radiology teams.

Together with our distribution partner, ITEM Corporation, we are inspired by the exchange of ideas and the momentum going forward.

15/04/2026

ESTRO 2026 is fast approaching. Once again, MVision AI will be returning to connect with the radiotherapy community.

Join us in Stockholm from 15–18 May at Booth C14:31 to exchange ideas, share experiences, and discuss the practical challenges shaping radiation oncology today.

Some of the expert MVisionaries in attendance will be:

Mahmudul Hasan, Founder and CEO
Saad Ullah Akram, Co-Founder & CTO
Gregory Bolard, Chief Scientific Officer
Britta Schürmann, Director of Sales EMEA
Jani Pehkonen, Product Owner
Norina Predescu, Radiation Oncologist
Rachel Buckingham, Product Marketing Manager
Hassan Hassan, Customer Success Specialist
Ekaterina Teploukhova, Junior Clinical Scientist

See you soon in Stockholm!

13/04/2026

We are heading back to Japan.

MVision AI will be attending the International Technical Exhibition of Medical Imaging 2026 (ITEM2026) in Yokohama on April 17–19. The exhibition highlights the latest developments in medical imaging and radiology, with a strong focus on technologies used in everyday clinical practice.

You can meet MVision Founder and CEO Mahmudul Hasan and Chief Scientific Officer Gregory Bolard together with our partner, ITEM Corporation, throughout the event.

Stop by booth D1-03 to learn how MVision AI can support real-world clinical environments.

*The technologies featured in this exhibition have not yet received regulatory approval and are currently not available for sale in Japan. For more information, please contact info@mvision.ai or info@item-corp.jp.

07/04/2026

AI is increasingly becoming part of everyday radiotherapy practice—but what does that look like in reality?

In our latest ‘Expert Perspectives: AI in Radiotherapy’ interview, Dr. Farshin Mortasawi, Holger Wirtz, and Mike Fröhlich from MVZ Strahlentherapie Singen-Friedrichshafen share their experience of integrating AI into clinical workflows. From AI-supported contouring to the future of AI-driven treatment planning, they reflect on how these technologies are improving efficiency, coordination, and preparation times.

They also explore the critical role of structured data, robust workflows, and strong collaboration between physics, IT, and clinical teams in making AI work in practice.

Read the full interview here: https://bit.ly/4t7jns8

02/04/2026

We're hiring a Customer IT Support Engineer to help deploy and support our software in hospitals and cancer centres across Europe.

This role is very hands-on — ensuring our systems run reliably in complex, regulated healthcare environments.

If this sounds like your kind of work, take a look here:
https://bit.ly/4cqluR5

We’re excited to welcome a new teammate on board!

02/04/2026

The Royal College of Radiologists has published new guidance on the safe use of AI auto-contouring in radiotherapy.

As AI becomes increasingly integrated into radiotherapy planning workflows, clear recommendations around commissioning, quality assurance, and clinical oversight are essential. The guidance highlights several key principles, including rigorous validation of models, structured review of auto-contours, and ongoing monitoring after clinical implementation.

These recommendations reflect an important point for the field: AI is most powerful when used responsibly, with clinicians firmly in the loop and robust quality processes in place.

It’s encouraging to see continued efforts from professional bodies to support the safe and effective adoption of AI technologies in radiation oncology.

Read the full article here: https://bit.ly/4bZ6Vn5

31/03/2026

Adaptive radiotherapy is becoming an important step forward in how radiation treatment responds to anatomical change.

During a multi-week treatment course, tumors and surrounding organs rarely stay in the same position or shape. New adaptive workflows allow clinicians to respond to these changes rather than rely only on a pre-treatment plan.

Advances in imaging, computing, and AI are making this approach increasingly practical in clinical settings.

We recently explored how adaptive radiotherapy is being used today, where it shows the most promise, and what current clinical evidence tells us.

Read more here: https://bit.ly/3ObfX8E

25/03/2026

MVision will be represented at the 6th International Congress of the Groupe Francophone de Radiothérapie en Urologie (GFRU), taking place March 26–27 in Lyon.

Our partner Meditest will be exhibiting at booth and will be available to discuss how MVision’s AI-powered solutions, including MVision Workspace+®, support efficient radiotherapy planning preparation while maintaining clinical oversight and consistent standards.

If you are attending the congress, be sure to stop by the booth to learn more.

CE-marked (CE 2797) medical device under EU MDR 2017/745; Workspace+ is not available in all markets.

23/03/2026

MVision AI Founder and CEO Mahmudul Hasan will attend the ASMIRT 2026 Conference, taking place in Hobart from March 26 to 29. Organized by ASMIRT, the event brings together the medical radiation science community for four days of education, collaboration, and professional development.

The conference will feature expert speakers, hands-on workshops, site visits, and networking opportunities, covering topics ranging from clinical practice and education to diversity, mentoring, and emerging technologies.

Join us along with our partner AlphaXRT at booth #34–36 to learn how MVision AI’s solutions—including our recently TGA-approved AI-powered platform MVision Workspace+®—support more efficient radiotherapy preparation workflows while promoting consistent quality and clinical oversight.

CE-marked (CE 2797) medical device under EU MDR 2017/745; Workspace+ is not available in all markets.

Osoite

PaciuksenKatu 29
Helsinki
00270

Nettisivu

http://www.mvision.ai/

Hälytykset

Tiedä ensimmäisenä ja anna meille oikeus lähettää sinulle sähköpostitse uutisia ja promootioita MVision AI :ltä. Sähköpostiosoitettasi ei käytetä muihin tarkoituksiin, ja voit perua milloin tahansa.

Oma vastaanotto listan huipulle Klinikka Helsinki :ssa?

Jaa

Kategoria

Terveys